Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.
作者信息
Klonoff David C, Umpierrez Guillermo E
机构信息
Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, United States of America.
Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States of America.
出版信息
Metabolism. 2020 Jul;108:154224. doi: 10.1016/j.metabol.2020.154224. Epub 2020 Apr 7.
Abstract
摘要
相似文献
1
Letter to the Editor: COVID-19 in patients with diabetes: Risk factors that increase morbidity.致编辑的信：糖尿病患者中的 COVID-19：增加发病率的风险因素。
Metabolism. 2020 Jul;108:154224. doi: 10.1016/j.metabol.2020.154224. Epub 2020 Apr 7.
2
Letter to the Editor: Endocrine and diabetes clinical practice during national lockdown and post lockdown period.致编辑的信：全国封锁期间及解封后时期的内分泌与糖尿病临床实践
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):479. doi: 10.1016/j.dsx.2020.04.037. Epub 2020 Apr 29.
3
Letter to the Editor: Mental Health and Psychological Distress in People with Diabetes during COVID-19.致编辑的信：2019冠状病毒病期间糖尿病患者的心理健康与心理困扰
Metabolism. 2020 Jul;108:154248. doi: 10.1016/j.metabol.2020.154248. Epub 2020 Apr 23.
4
Is the COVID-19 Pandemic an Opportunity to Enlarge the Telemedicine Boundaries?新冠疫情是扩大远程医疗边界的契机吗？
Telemed J E Health. 2020 Sep;26(9):1123-1125. doi: 10.1089/tmj.2020.0159. Epub 2020 May 26.
5
Letter to the editor in response to the article "COVID-19 and diabetes: Can DPP4 inhibition play a role?".致编辑的信：回应文章《2019冠状病毒病与糖尿病：二肽基肽酶4抑制能否发挥作用？》
Diabetes Res Clin Pract. 2020 May;163:108163. doi: 10.1016/j.diabres.2020.108163. Epub 2020 Apr 23.
6
Diabetes care during COVID 19: Experience in telemedicine from a developing country.2019冠状病毒病期间的糖尿病护理：一个发展中国家的远程医疗经验
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1519. doi: 10.1016/j.dsx.2020.07.046. Epub 2020 Aug 4.
7
Letter to the editor in response to: Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians.致编辑的信：回应《COVID-19大流行和全国封锁期间印度糖尿病护理的远程医疗：医生指南》
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):687-688. doi: 10.1016/j.dsx.2020.05.027. Epub 2020 May 19.
8
Family Member Visits to Critically Ill Patients During COVID-19: A New Pathway.新冠疫情期间家庭成员对重症患者的探访：一条新途径。
Telemed J E Health. 2020 Jul;26(7):853-854. doi: 10.1089/tmj.2020.0097. Epub 2020 Apr 21.
9
Clinical Management of Nonrespiratory Diseases in the COVID-19 Pandemic: What Have We Done and What Needs to Be Done?新冠疫情期间非呼吸道疾病的临床管理：我们做了什么以及需要做什么？
Telemed J E Health. 2020 Oct;26(10):1206-1208. doi: 10.1089/tmj.2020.0148. Epub 2020 May 19.
10
Letter: The Risk of Diabetes on Clinical Outcomes in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study ( 2020;44:405-13).信函：2019冠状病毒病患者糖尿病对临床结局的风险：一项回顾性队列研究（2020年；44：405 - 13）
Diabetes Metab J. 2020 Aug;44(4):621-622. doi: 10.4093/dmj.2020.0151.
引用本文的文献
1
The Link between Inflammation, Lipid Derivatives, and Microbiota Metabolites in COVID-19 Patients: Implications on Eating Behaviors and Nutritional Status.COVID-19 患者炎症、脂类衍生物与肠道菌群代谢物之间的关联：对饮食行为和营养状况的影响。
Int J Mol Sci. 2024 Jul 19;25(14):7899. doi: 10.3390/ijms25147899.
2
Enhancing COVID-19 Knowledge among Nursing Students: A Quantitative Study of a Digital Serious Game Intervention.提高护理专业学生对新冠病毒的认知：一项关于数字严肃游戏干预的定量研究
Healthcare (Basel). 2024 May 23;12(11):1066. doi: 10.3390/healthcare12111066.
3
Obesity, Race, and COVID-19 Mortality: Results from a Large Cohort Early in the Pandemic.肥胖、种族与新冠病毒疾病死亡率：疫情早期一项大型队列研究的结果
HCA Healthc J Med. 2021 Aug 29;2(4):279-288. doi: 10.36518/2689-0216.1276. eCollection 2021.
4
Lethality risk markers by sex and age-group for COVID-19 in Mexico: a cross-sectional study based on machine learning approach.墨西哥 COVID-19 按性别和年龄组划分的致死风险标志物：基于机器学习方法的横断面研究。
BMC Infect Dis. 2023 Jan 11;23(1):18. doi: 10.1186/s12879-022-07951-w.
5
COVID-19 effect on patients with noncommunicable diseases: A narrative review.2019冠状病毒病对非传染性疾病患者的影响：一项叙述性综述。
Health Sci Rep. 2022 Dec 15;6(1):e995. doi: 10.1002/hsr2.995. eCollection 2023 Jan.
6
Obesity, Diabetes Mellitus, and Metabolic Syndrome: Review in the Era of COVID-19.肥胖、糖尿病和代谢综合征：COVID-19时代的综述
Clin Nutr Res. 2022 Oct 24;11(4):331-346. doi: 10.7762/cnr.2022.11.4.331. eCollection 2022 Oct.
7
Factors Associated With Mortality Among the COVID-19 Patients Treated at Gulu Regional Referral Hospital: A Retrospective Study.《在古卢地区转诊医院接受治疗的 COVID-19 患者的死亡相关因素：一项回顾性研究》。
Front Public Health. 2022 Apr 11;10:841906. doi: 10.3389/fpubh.2022.841906. eCollection 2022.
8
Diabetes and COVID-19; A Bidirectional Interplay.糖尿病与2019冠状病毒病：一种双向相互作用
Front Endocrinol (Lausanne). 2022 Feb 17;13:780663. doi: 10.3389/fendo.2022.780663. eCollection 2022.
9
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review : PCOS and COVID-19 relationship.多囊卵巢综合征与 COVID-19 感染风险：全面综述：PCOS 与 COVID-19 的关系。
Rev Endocr Metab Disord. 2022 Apr;23(2):251-264. doi: 10.1007/s11154-022-09715-y. Epub 2022 Feb 26.
10
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19.炎症、高血糖与 COVID-19 住院糖尿病患者的不良结局。
Diabetes Care. 2022 Mar 1;45(3):692-700. doi: 10.2337/dc21-2102.
本文引用的文献
1
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
2
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).拯救脓毒症运动：2019 冠状病毒病（COVID-19）危重症成人管理指南。
Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.
3
Commentary: COVID-19 in patients with diabetes.评论：糖尿病患者中的2019冠状病毒病
Metabolism. 2020 Jun;107:154217. doi: 10.1016/j.metabol.2020.154217. Epub 2020 Mar 24.
4
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎（COVID-19）的风险会增加吗？
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
5
Virtually Perfect? Telemedicine for Covid-19.近乎完美？用于新冠疫情的远程医疗
N Engl J Med. 2020 Apr 30;382(18):1679-1681. doi: 10.1056/NEJMp2003539. Epub 2020 Mar 11.
6
Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital.糖尿病技术更新：医院中胰岛素泵和连续血糖监测的使用。
Diabetes Care. 2018 Aug;41(8):1579-1589. doi: 10.2337/dci18-0002. Epub 2018 Jun 23.
7
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes.共识报告：血糖自我监测在非胰岛素治疗的2型糖尿病中的当前作用
J Diabetes Sci Technol. 2011 Nov 1;5(6):1529-48. doi: 10.1177/193229681100500630.
8
Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS.血糖水平和糖尿病是严重急性呼吸综合征（SARS）患者死亡率和发病率的独立预测因素。
Diabet Med. 2006 Jun;23(6):623-8. doi: 10.1111/j.1464-5491.2006.01861.x.
9
SARS: epidemiology.严重急性呼吸综合征：流行病学
Respirology. 2003 Nov;8 Suppl(Suppl 1):S9-14. doi: 10.1046/j.1440-1843.2003.00518.x.
Zotero 插件